Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)

• Status: Completed
• Trial end date: 2006-01-31
• Target enrollment: 0
• Participant gender: Female

Summary

Allow gynecologists to gain experience with arcoxia for treatment of dysmenorrhea.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Etoricoxib

Criteria

Inclusion Criteria:

• Healthy women older than 18 years old and younger than 25 years old

• Voluntary agreement to participate in the study and signature of informed consent

• Women with clinical diagnosis of dysmenorrhea

Exclusion Criteria:

• Diagnosis of secondary dysmenorrhea due to: endometriosis, adenomyosis, malformations of Muller's conducts, uterine fibromyomas, ovarian cystic, pelvic varicocoele, inflammatory pelvic disease, adherences, intrauterine devices, cervical channel stenosis, etc.

• Patients with diagnosis of acute inflammatory abdomen

• Patients with diagnosis of congestive heart disease, stroke (1 year), unstable angina, and history of myocardial infarction

• Women auto prescribing rescue medication for dysmenorrheal pain during the study

• Women with a diagnosis of mild dysmenorrhea